Discovery, whose share price has been knocked by the advancement of the controversial National Health Insurance (NHI) Bill, says while the legislation’s restriction of SA’s medical schemes would be counterproductive, it would not be a death knell for the industry.

Discovery’s valuation has declined by almost a third over the past two months, partly on concerns about what the NHI will mean for private healthcare operators once fully implemented…..more

MPs seek assurance on constitutionality of NHI Bill

Pilot NHI projects a failure, says Denosa